Immunocore Holdings (IMCR) Receivables Refunds (2021 - 2023)
Historic Receivables Refunds for Immunocore Holdings (IMCR) over the last 3 years, with Q4 2023 value amounting to $3.5 million.
- Immunocore Holdings' Receivables Refunds fell 6168.23% to $3.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.5 million, marking a year-over-year decrease of 6168.23%. This contributed to the annual value of $3.5 million for FY2023, which is 6168.23% down from last year.
- Immunocore Holdings' Receivables Refunds amounted to $3.5 million in Q4 2023, which was down 6168.23% from $9.2 million recorded in Q4 2022.
- In the past 5 years, Immunocore Holdings' Receivables Refunds ranged from a high of $13.0 million in Q3 2021 and a low of $2.6 million during Q2 2022
- Moreover, its 3-year median value for Receivables Refunds was $7.9 million (2021), whereas its average is $7.9 million.
- As far as peak fluctuations go, Immunocore Holdings' Receivables Refunds crashed by 2715.6% in 2022, and later crashed by 6168.23% in 2023.
- Over the past 3 years, Immunocore Holdings' Receivables Refunds (Quarter) stood at $12.7 million in 2021, then fell by 27.16% to $9.2 million in 2022, then crashed by 61.68% to $3.5 million in 2023.
- Its Receivables Refunds was $3.5 million in Q4 2023, compared to $9.2 million in Q4 2022 and $2.6 million in Q2 2022.